HCA Healthcare Inc. ($HCA) Stock Forecast: Down 9.1% Today

What is HCA Healthcare Inc.?

HCA Healthcare (NYSE: HCA) is a leading hospital operator in the healthcare industry, providing a wide range of medical services to patients. The stock experienced a significant bearish movement today amidst the release of its Q1 2026 earnings report.

Why is HCA Healthcare Inc. going down?

HCA stock is down 9.1% on Apr 24, 2026 18:35

• Despite reporting a 4.3% increase in revenues and a 10.9% rise in diluted EPS, HCA Healthcare's stock took a hit due to lower respiratory-related admissions and the impact of a winter storm on patient volumes.
• The company's reaffirmation of its 2026 guidance, including expectations of 2-3% volume growth for the remainder of the year, was not enough to offset concerns about the softer respiratory season and dynamic environment.
• Investors may have reacted negatively to the mixed same-facility volume trends and the ongoing challenges related to health insurance exchanges and Medicaid conversions, leading to the bearish movement in HCA's stock price today.

HCA Price Chart

HCA Technical Analysis

HCA News

Why Is HCA Healthcare Stock Tanking Friday? - HCA Healthcare (NYSE:HCA)

HCA Healthcare's stock is down after the company reported Q1 2026 earnings, primarily due to a softer respiratory season and a January winter storm affecting patient volumes. Despite this, the hospital operator reaffirmed its 2026 guidance for earnings and sales, which are in line with analyst consensus. The company reported adjusted earnings of $7.15 per share and revenues of $19.11 billion, with mixed same-facility volume trends.

https://www.benzinga.com/markets/earnings/26/04/52041810/hospital-operator-hca-healthcare-flags-soft-respiratory-season-as-volumes-lag

HCA Healthcare Q1 2026 Earnings Call Transcript

HCA Healthcare reported a 4.3% revenue increase and an almost 2% adjusted EBITDA increase in Q1 2026, with diluted EPS up 11%, despite a milder respiratory season and winter storms impacting volumes. Strategic initiatives include digital transformation, AI, network expansion, and the company reaffirmed its full-year guidance expecting 2-3% volume growth for the remainder of the year and maintaining its outlook on health insurance exchanges. State supplemental programs provided a significant net benefit, helping to offset volume shortfalls, although the impact of insurance exchanges and Medicaid conversions remains dynamic.

https://www.benzinga.com/insights/news/26/04/52035033/hca-healthcare-q1-2026-earnings-call-transcript

HCA Healthcare, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

HCA Healthcare, Inc. announced its earnings results for the first quarter ended March 31, 2026. The company reported sales of $19,109 million, an increase from $18,321 million in the prior year, and a net income of $1,620 million, up from $1,610 million. Diluted earnings per share from continuing operations rose to $7.15 compared to $6.45 a year ago.

https://www.marketscreener.com/news/hca-healthcare-inc-reports-earnings-results-for-the-first-quarter-ended-march-31-2026-ce7f59dfdd8ff423

HCA Healthcare Reports First Quarter 2026 Results

HCA Healthcare announced its first-quarter 2026 financial results, with revenues increasing 4.3% to $19.109 billion and diluted EPS rising 10.9% to $7.15. The company repurchased $1.571 billion of its common stock and declared a quarterly cash dividend of $0.78 per share. Despite a dynamic environment and lower respiratory-related admissions, HCA Healthcare reaffirmed its 2026 guidance.

https://www.pharmiweb.com/press-release/2026-04-24/hca-healthcare-reports-first-quarter-2026-results

Universal Beteiligungs und Servicegesellschaft mbH Buys 6,095 Shares of ResMed Inc. $RMD

Universal Beteiligungs und Servicegesellschaft mbH increased its stake in ResMed Inc. by 6.1% during the fourth quarter, purchasing an additional 6,095 shares to own a total of 105,621 shares valued at approximately $25.5 million. ResMed reported strong earnings, beating consensus estimates with $2.81 EPS and $1.42 billion in revenue, leading to a "Moderate Buy" consensus rating among analysts with an average price target of $295.64. The company also declared a quarterly dividend of $0.60 per share.

https://www.marketbeat.com/instant-alerts/filing-universal-beteiligungs-und-servicegesellschaft-mbh-buys-6095-shares-of-resmed-inc-rmd-2026-04-24/

Trending Today

HCA Healthcare Inc. Price History

11.01.2026 - HCA Stock was up 5.0%

• The reduction in stake by Prospera Financial Services Inc. did not deter other institutional investors like Norges Bank and Viking Global Investors LP from increasing their positions in HCA, indicating confidence in the company's growth prospects.
• HCA's robust financial performance, beating EPS estimates, issuing optimistic guidance, and raising its dividend, likely contributed to the bullish movement in its stock price.
• The upcoming community meetings regarding HCA Mission Health System may have also generated positive sentiment among investors, showcasing transparency and accountability in the company's operations.
• HCA's strategic focus on expanding market presence, enhancing digital capabilities, and managing risks highlighted in its SEC 10-K report further solidifies investor confidence in the company's long-term sustainability and growth potential.

05.00.2026 - HCA Stock was up 1.7%

• HCA Healthcare's stock rallied steadily due to strong fundamentals, consistent guidance, and a focus on returning cash to shareholders, attracting investor attention away from tech giants.
• The reduction in stake by Gateway Investment Advisers LLC and an EVP could indicate profit-taking after strong Q3 earnings and price target upgrades, contributing to the stock's positive momentum.
• The adoption of advanced robotics for orthopedic surgeries at Marion County HCA Hospitals showcases HCA's commitment to innovation and improving patient outcomes, potentially boosting investor confidence in the company's growth prospects.
• Despite a lower P/E ratio compared to the broader market, investors remain cautious about HCA Healthcare's future earnings volatility or potential threats, reflecting a sense of uncertainty despite the positive market outlook.

24.03.2026 - HCA Stock was down 8.2%

• HCA Healthcare saw a decline in its stock price despite posting strong first-quarter financial results.
• Factors contributing to the stock's drop include weak volume trends, specifically lower admissions and emergency room visits related to respiratory issues.
• Concerns about the company's valuation arose following mixed Q1 results – a miss in diluted EPS estimates but a beat in revenue expectations.
• Investor sentiment may have been influenced by the company's leverage and insider selling, as per observations by GuruFocus.

24.03.2026 - HCA Stock was down 9.1%

• Despite reporting a 4.3% increase in revenues and a 10.9% rise in diluted EPS, HCA Healthcare's stock took a hit due to lower respiratory-related admissions and the impact of a winter storm on patient volumes.
• The company's reaffirmation of its 2026 guidance, including expectations of 2-3% volume growth for the remainder of the year, was not enough to offset concerns about the softer respiratory season and dynamic environment.
• Investors may have reacted negatively to the mixed same-facility volume trends and the ongoing challenges related to health insurance exchanges and Medicaid conversions, leading to the bearish movement in HCA's stock price today.

24.03.2026 - HCA Stock was down 9.9%

• Despite reporting first-quarter results that slightly beat analyst expectations, HCA Healthcare experienced a significant bearish movement, dropping nearly 8%.
• The stock's decline can be attributed to weak volume trends, including a notable decrease in respiratory-related admissions and emergency room visits, as well as the absence of typical seasonal increases.
• Concerns about the company being overvalued, highlighted by GuruFocus, with a GF Value of $431.18 versus the current price of $474.03, might have also contributed to the bearish sentiment.
• The market's reaction could also be influenced by the mixed Q1 2026 results, with diluted EPS missing estimates but revenue beating expectations, leading to uncertainty among investors about the company's future performance.

27.00.2026 - HCA Stock was up 6.5%

• Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst projections and resulting in a bullish trend in its stock price.
• Investor enthusiasm was fueled by the company's announcement of a new $10 billion share repurchase plan and an uptick in the quarterly dividend.
• Despite a slight miss in revenue expectations for Q4, HCA Healthcare's focus on profitability, sustained EPS growth, and ambitious financial objectives for 2026 provided a favorable perspective for investors.
• Confidence in HCA Healthcare's performance and future prospects was bolstered by Markel Group Inc.'s increased stake and the overall positive sentiment from analysts and institutional investors.

17.02.2026 - HCA Stock was down 5.2%

• An increase in holdings by Mercer Global Advisors Inc. ADV in HCA Healthcare could reflect confidence in the company's future prospects, although market sentiment may have been influenced by various factors.
• Despite HCA Healthcare's strong performance and strategic investments, notable insider selling activities in the healthcare sector, involving CEOs and Directors of companies like ResMed Inc. and Tenet Healthcare Corporation, might have had a negative impact on investor sentiment.
• Analysts supporting a "Moderate Buy" rating for HCA Healthcare amidst insider selling and institutional adjustments present a mixed outlook, potentially contributing to the stock's bearish movement.
• HCA Healthcare's emphasis on AI-driven efficiencies and disciplined capital deployment for future growth, highlighted in industry conferences, contrasts with insider selling trends in the sector, complicating market dynamics and potentially affecting the stock price adversely.

27.00.2026 - HCA Stock was up 7.1%

• Strong Q4 earnings were reported by HCA Healthcare, surpassing analyst expectations and resulting in a bullish movement in the stock.
• Investor confidence was further boosted by the company's announcement of a new $10 billion share repurchase program and an increased quarterly dividend.
• Despite a cautious revenue guidance for 2026, HCA Healthcare's commitment to profitability and continued EPS growth highlighted its ability to effectively navigate a stable operating environment.
• The positive market sentiment towards HCA Healthcare was evident through increased institutional investments, with entities like Markel Group Inc. acquiring additional shares, indicating a growing confidence in the company's performance and future prospects.

28.00.2026 - HCA Stock was down 5.3%

• Despite reporting strong Q4 earnings, HCA Healthcare's stock experienced a bearish movement as the cautious revenue guidance for 2026 fell below analyst expectations.
• The announcement of a new $10 billion share repurchase program and an increased quarterly dividend were not enough to offset concerns about the company's future revenue growth.
• The market may be reacting negatively to economic headwinds, which could impact HCA's revenue projections for the upcoming year.
• The bullish sentiment on outpatient expansion might not have been sufficient to reassure investors about the company's overall growth prospects, leading to the bearish movement in the stock price.

11.01.2026 - HCA Stock was up 6.6%

• Unusual options activity on HCA Healthcare, with predominantly bullish trades and a price window of $350.0 to $560.0, signals a positive sentiment among investors, propelling the stock price higher.
• The reduction in stake by Prospera Financial Services Inc. may have initially raised concerns, but increased positions by other institutional investors and robust quarterly earnings report surpassing EPS estimates and raising dividends have reassured investors and fueled the bullish trend.
• The upcoming community meetings to discuss updates on HCA Mission Health System could be viewed as a favorable move towards transparency and accountability, potentially enhancing investor confidence in HCA Healthcare's operations and future outlook.

12.01.2026 - HCA Stock was up 5.7%

• A notable reduction in LSV Asset Management's stake in HCA Healthcare by 2.9% initially raised concerns but did not dampen market sentiment due to the company's robust financial performance.
• The increase in earnings estimates for HCA Healthcare by Zacks Research, along with a "Hold" rating, indicates rising confidence in the company's future prospects, contributing to the positive market movement.
• HCA's stock hitting a new 52-week high and receiving an "Outperform" rating from analysts reflects investors' optimism about its ongoing growth and profitability.
• Despite a slight decrease in the Q1 2026 EPS estimate and an insider share sale causing some negative sentiment, the overall positive news of strong earnings, dividend increase, and strategic expansion into outpatient services drove HCA's stock to new highs.

12.02.2026 - HCA Stock was up 2.7%

• HCA Healthcare is a leading healthcare services provider in the US, offering a wide range of medical services to patients.
• The overall market sentiment for HCA Healthcare has been positive, with strong bullish movement today.
• Franklin Resources Inc. reducing its stake in HCA Healthcare did not hinder the company's performance, as it surpassed quarterly EPS expectations, raised its dividend, and received a "Moderate Buy" rating from analysts, leading to increased investor confidence.
• First Trust Advisors LP increasing its shares in HCA Healthcare suggests growing institutional interest, which has further bolstered market sentiment.
• The optimistic prospects for HCA Healthcare, coupled with the rise in quarterly dividend, likely contributed to the surge in the stock price today.